Medical Hypnosis and hypnotherapy in Castro Valley in East Bay Castro Valley California near San Francisco Bay Area near San Leandro, Oakland, Hayward, Pleasanton, Union City, and Fremont. Medical hypnosis for pain control, pain management, hypnotic stress reduction, weight loss, self-hypnosis, smoking cessation. Close to Castro Vally Bart and to all Castro Valley centers. Do not let pain dominate your life, take control of your life, manage your discomfort, relax yourself, release the stress. Clinical hypnosis in Castro Valley, Fremont, Union City, Hayward, San Leandro, San Lorenzo in the East Bay Area near San Francisco, California.
20990 Redwood Road Castro Valley, California, USA
Directions
From SAN FRANCISCO or OAKLAND via 580 • Turn LEFT onto STROBRIDGE AVE. 0.18 miles • Turn RIGHT onto CASTRO VALLEY BLVD. 0.39 miles • At the intersection with ANITA AVE., turn RIGHT into the parking lot at 2881 CASTRO VALLEY BLVD
From SAN JOSE, PENINSULA, or OAKLAND via 880 • Merge onto I-238 S toward I-580/CASTRO VALLEY/STOCKTON. 2.08 miles • Take the CA-238/Redwood Road exit. 0.11 miles • Take the Redwood Road ramp. 0.32 miles • Turn LEFT onto Redwood Road. 0.86 miles • , turn RIGHT into the parking lot at Castro Valley Plaza at 20990 Redwood Road
From CASTRO VALLEY BART • Turn LEFT onto Redwood Road •., cross the street into the parking lot at 220990 Redwood Road
From PLEASANTON or DUBLIN • Take I-580 W toward OAKLAND. Take Redwood Road exit • Turn Right onto Redwood Road. 0.39 miles • turn RIGHT into the parking lot at Castro Valley Plaza at 20990 Redwood Road

August 15, 2006

Suggested Guided Imagery for Metabolic Syndrome

According to a new article from researchers at Harvard there is a "switch" to turn on a fat and cholesterol production regulator within the cells. I believe, as I have mentioned before, that we can and should add "true life" imagery to our hypnotic suggestions.

It is a rather complex article from Science Daily.com but for those of you who are interested....here it is.


Key Fat And Cholesterol Cell Regulator Identified, Promising Target

07 Aug 2006

Researchers at Harvard Medical School and Massachusetts General Hospital have
identified how a molecular switch regulates fat and cholesterol production, a step
that may help advance treatments for metabolic syndrome, the constellation of
diseases that includes high cholesterol, obesity, type II diabetes, and high blood
pressure. The study is now published in the online version of the scientific journal
Nature and will appear in the August 10th print edition.

"We have identified a key protein that acts together with a family of molecular
switches to turn on cholesterol and fat (or lipid) production," says principal
investigator Anders Naar, PhD, assistant professor of cell biology at Harvard
Medical School and the Massachusetts General Hospital Cancer Center. "The
identification of this protein interaction and the nature of the molecular interface
may one day allow us to pursue a more comprehensive approach to the treatment of
metabolic syndrome."

High levels of cholesterol and lipids are linked to a number of interrelated medical
conditions and diseases, including obesity, type II diabetes, fatty liver, and high
blood pressure. This set of conditions and diseases, known as metabolic syndrome,
are afflicting a rapidly increasing portion of society and serve as a major risk
factor for heart disease, the leading cause of death in the developed world.

Treatments for diseases associated with metabolic syndrome have focused primarily on
individual elements, such as high LDL-cholesterol (targeted by the
cholesterol-lowering statin drugs). However, more effective ways to treat all of the
components of metabolic syndrome are needed. One attractive approach might be to
target the genetic switches that promote cholesterol and lipid synthesis, but it
would require a detailed understanding of the regulatory mechanisms before drug
targets can be identified.

After eating a meal, a family of proteins act as switches to turn on cholesterol and
fat (or lipid) production. This family of proteins is known as SREBPs, or sterol
regulatory element binding proteins. Between meals, the production of cholesterol
and lipids should be turned off, however, excess intake of foods, coupled with lack
of exercise, appear to disturb the normal checks and balances that control SREBPs,
resulting in overproduction of cholesterol and lipids.

In the Nature paper, the HMS and MGH Cancer Center team has shown that a protein
called ARC105, which binds to SREBPs, is essential in controlling the activity of
the SREBP family of proteins. "ARC105 represents a lynchpin for SREBPs control of
cholesterol and lipid biosynthesis genes, which may provide a potential molecular
Achilles heel that could be targeted by drugs" says Dr. Naar.

The researchers initially found that after removing ARC105 from human cells by a
process called RNAi, SREBPs were no longer able to activate cholesterol and lipid
biosynthesis genes. To validate these findings in a physiological setting, the
researchers turned to the microscopic worm C. elegans, a favorite model organism
among those studying evolutionarily conserved biological processes because of its
rapid generation time and relative simplicity of genetics, and which had previously
been used to study mechanisms of fat regulation.

Through a collaborative effort with the worm genetics group of Anne Hart, PhD, HMS
associate professor of pathology at the MGH Cancer Center, the team demonstrated
that the C. elegans homologues of SREBP and ARC105, known as SBP-1 and MDT-15,
respectively, are necessary for production and storage of fat. The worms had regular
fat production when SBP-1 and MDT-15 functioned normally, but when researchers used
RNAi to knock out function of either SBP-1 or MDT-15, the worms lost their ability
to properly store fat, lay eggs, and move normally.

"The striking effects of the RNAi knock downs in C. elegans suggest that the
ARC105/SREBP pathway may play a key role in lipid production in humans," said Laurie
Tompkins, PhD, of the National Institute of General Medical Sciences, which
partially supported the research. "This work highlights the value of model organisms
in helping us understand cellular processes that impact human health."

The research team also showed that removal of ARC105 in human cells by RNAi also
negatively affects the same key SREBP target gene as identified in C. elegans. This
suggests that the molecular switch is evolutionarily conserved (and therefore likely
physiologically important).

Exhaustive biochemical detective work performed by the Naar group together with the
group of Gerhard Wagner, PhD, HMS professor in the Department of Biological
Chemistry and Molecular Pharmacology, identified exactly how SREBP and ARC105
interact. They found a flexible tail on the SREBP molecule that fits into a specific
groove on a region of ARC105 called KIX.

The researchers analyzed the amino acid sequence of the ARC105 protein, testing many
different sections using NMR spectroscopy to eventually find the KIX area--just one
tenth the area of the larger ARC105 protein--that specifically binds to SREBP. This
specific interaction between SREBP and ARC105 might be a target for small molecule
drugs, according to Dr. Wagner.

"While RNAi completely knocks out a protein including its other functions, perhaps
not related to fat metabolism, a small molecule is a more subtle tool that could
eliminate one protein-to-protein interaction," says Dr. Wagner. Finding a molecule
that attaches to and inhibits the flexible tail of SREBP is unlikely, but a search
for inhibitors to fit the grooved KIX site looks much more promising.

The team is already initiating high-throughput screening at Harvard Medical School's
Institute of Chemistry and Cell Biology to identify small molecule inhibitors of the
KIX site.

"Of course there are numerous hurdles that would need to be overcome before finding
specific and effective treatments based on these findings," says Dr. Naar. If small
molecules that specifically interfere with the interaction of SREBPs and ARC105
could be identified, careful studies in human cells and in mice would be needed to
verify the specificity and efficacy in repressing cholesterol and fat production.
"Unforeseen side effects of such small molecules in mouse studies or in human
clinical trials could also emerge, prohibiting further follow-up", cautions Dr.
Naar.


Article URL: http://www.medicalnewstoday.com/medicalnews.php?newsid=48733
Mar 26, 2005 Mar 29, 2005 Apr 2, 2005 Apr 3, 2005 Apr 4, 2005 Apr 5, 2005 Apr 6, 2005 Apr 8, 2005 Apr 9, 2005 Apr 10, 2005 Apr 11, 2005 Apr 13, 2005 Apr 14, 2005 Apr 16, 2005 Apr 18, 2005 Apr 19, 2005 Apr 25, 2005 Apr 26, 2005 May 1, 2005 May 4, 2005 May 5, 2005 May 6, 2005 May 8, 2005 May 11, 2005 May 13, 2005 May 16, 2005 May 17, 2005 May 20, 2005 May 22, 2005 May 25, 2005 May 29, 2005 Jun 11, 2005 Jun 24, 2005 Jun 28, 2005 Jun 29, 2005 Jun 30, 2005 Jul 14, 2005 Jul 21, 2005 Jul 27, 2005 Jul 29, 2005 Jul 31, 2005 Aug 3, 2005 Aug 7, 2005 Aug 20, 2005 Aug 22, 2005 Sep 6, 2005 Sep 8, 2005 Sep 9, 2005 Sep 13, 2005 Sep 16, 2005 Sep 17, 2005 Sep 18, 2005 Oct 11, 2005 Oct 23, 2005 Oct 24, 2005 Oct 26, 2005 Oct 31, 2005 Nov 22, 2005 Nov 25, 2005 Dec 5, 2005 Dec 17, 2005 Dec 22, 2005 Jan 17, 2006 Jan 27, 2006 Mar 13, 2006 Mar 15, 2006 Mar 22, 2006 Mar 24, 2006 Mar 25, 2006 Mar 27, 2006 Mar 29, 2006 Mar 30, 2006 Mar 31, 2006 Apr 10, 2006 Apr 14, 2006 Apr 22, 2006 Apr 23, 2006 Apr 24, 2006 Apr 25, 2006 Apr 28, 2006 Apr 29, 2006 May 9, 2006 May 14, 2006 May 16, 2006 May 24, 2006 Jun 20, 2006 Jun 26, 2006 Jun 28, 2006 Jun 29, 2006 Jul 14, 2006 Jul 18, 2006 Jul 21, 2006 Jul 23, 2006 Jul 24, 2006 Jul 26, 2006 Jul 27, 2006 Jul 28, 2006 Jul 30, 2006 Aug 15, 2006 Aug 18, 2006 Aug 19, 2006 Aug 22, 2006 Aug 28, 2006 Aug 30, 2006 Aug 31, 2006 Sep 1, 2006 Sep 12, 2006 Sep 14, 2006 Sep 15, 2006 Sep 16, 2006 Sep 17, 2006 Sep 18, 2006 Sep 19, 2006 Sep 20, 2006 Sep 24, 2006 Sep 27, 2006 Sep 28, 2006 Sep 29, 2006 Oct 3, 2006 Oct 6, 2006 Oct 13, 2006 Oct 18, 2006 Oct 19, 2006 Oct 29, 2006 Oct 31, 2006 Nov 1, 2006 Nov 3, 2006 Nov 6, 2006 Nov 7, 2006 Nov 8, 2006 Nov 10, 2006 Nov 11, 2006 Nov 13, 2006 Nov 14, 2006 Nov 17, 2006 Nov 26, 2006 Nov 28, 2006 Nov 30, 2006 Dec 1, 2006 Dec 2, 2006 Dec 8, 2006 Dec 10, 2006 Dec 11, 2006 Dec 12, 2006 Dec 13, 2006 Dec 17, 2006 Dec 18, 2006 Dec 19, 2006 Dec 23, 2006 Dec 25, 2006 Dec 27, 2006 Dec 30, 2006 Jan 7, 2007 Jan 13, 2007 Jan 18, 2007 Jan 22, 2007 Jan 26, 2007 Feb 1, 2007 Feb 16, 2007 Feb 17, 2007 Feb 18, 2007 May 14, 2007 May 18, 2007 May 24, 2007 May 26, 2007 Jun 2, 2007 Jun 5, 2007 Aug 8, 2007 Aug 28, 2007 Nov 11, 2007 Nov 12, 2007 Nov 15, 2007 Feb 14, 2008 Feb 20, 2008 Feb 28, 2008 Mar 2, 2008 Mar 3, 2008 Apr 2, 2008 Apr 3, 2008 Apr 13, 2008 May 28, 2008 Jun 4, 2008 Jun 11, 2008 Jun 29, 2008 Jul 27, 2008 Aug 15, 2008 Aug 17, 2008 Sep 8, 2008 Sep 13, 2008 Sep 16, 2008 Sep 30, 2008 Oct 3, 2008 Oct 8, 2008 Oct 15, 2008 Oct 22, 2008 Oct 25, 2008 Oct 31, 2008 Nov 1, 2008 Nov 14, 2008 Nov 21, 2008 Dec 1, 2008 Dec 9, 2008 Dec 12, 2008 Dec 24, 2008 Dec 27, 2008 Dec 29, 2008 Jan 19, 2009 Jan 26, 2009 Feb 2, 2009 Feb 11, 2009 Feb 18, 2009 Feb 20, 2009 Feb 25, 2009 Mar 3, 2009 Mar 8, 2009 Mar 13, 2009 Mar 31, 2009 Apr 6, 2009 Apr 11, 2009 Apr 16, 2009 Apr 20, 2009 Apr 21, 2009 Apr 26, 2009 May 2, 2009 May 8, 2009 May 9, 2009 May 12, 2009 May 13, 2009 May 18, 2009 Jun 7, 2009 Jun 24, 2009 Jun 30, 2009 Jul 1, 2009 Jul 8, 2009 Jul 14, 2009 Jul 22, 2009 Jul 24, 2009 Jul 25, 2009 Jul 26, 2009 Aug 16, 2009 Sep 1, 2009 Sep 7, 2009 Sep 8, 2009 Sep 15, 2009 Sep 25, 2009 Sep 30, 2009 Oct 6, 2009 Oct 10, 2009 Oct 13, 2009 Oct 14, 2009 Oct 21, 2009 Oct 25, 2009 Nov 4, 2009 Nov 10, 2009 Nov 14, 2009 Nov 17, 2009 Nov 22, 2009 Nov 28, 2009 Dec 4, 2009 Dec 14, 2009 Dec 15, 2009 Dec 23, 2009 Dec 24, 2009 Jan 4, 2010 Jan 10, 2010 Jan 17, 2010 Jan 24, 2010 Feb 13, 2010 Feb 20, 2010 Feb 25, 2010 Feb 28, 2010 Mar 9, 2010 Mar 18, 2010 Mar 27, 2010 Mar 31, 2010 Apr 1, 2010 Apr 13, 2010 Apr 29, 2010 May 4, 2010 May 19, 2010 May 20, 2010 May 25, 2010 Jun 1, 2010 Jun 2, 2010 Jun 9, 2010 Jun 26, 2010 Jul 1, 2010 Aug 16, 2010 Aug 18, 2010 Aug 21, 2010 Sep 8, 2010 Sep 11, 2010 Sep 19, 2010 Sep 26, 2010 Oct 5, 2010 Oct 26, 2010 Nov 9, 2010 Nov 16, 2010 Nov 17, 2010 Nov 19, 2010 Nov 26, 2010 Dec 15, 2010 Dec 20, 2010 Jan 15, 2011 Jan 16, 2011 Jan 19, 2011 Jan 25, 2011 Jan 31, 2011 Feb 5, 2011 Feb 8, 2011 Feb 9, 2011 Feb 10, 2011 Feb 14, 2011 Feb 15, 2011 Feb 16, 2011 Feb 18, 2011 Feb 28, 2011 Mar 1, 2011 Mar 4, 2011 Mar 6, 2011 Apr 9, 2011 Apr 12, 2011 Apr 13, 2011 Apr 15, 2011 Apr 16, 2011 Apr 17, 2011 Apr 28, 2011 Jun 2, 2011 Jun 3, 2011 Jun 4, 2011 Jun 7, 2011 Jun 10, 2011 Jun 12, 2011 Jun 13, 2011 Jun 14, 2011 Jun 16, 2011 Jun 18, 2011 Jun 20, 2011 Jun 23, 2011 Jul 7, 2011 Jul 15, 2011 Jul 19, 2011 Jul 21, 2011 Jul 22, 2011 Jul 24, 2011 Jul 25, 2011 Jul 28, 2011 Jul 30, 2011 Jul 31, 2011 Aug 1, 2011 Aug 2, 2011 Aug 19, 2011 Sep 8, 2011 Sep 13, 2011 Sep 16, 2011 Sep 25, 2011 Oct 5, 2011 Oct 11, 2011 Oct 28, 2011 Dec 4, 2011 Dec 5, 2011 Dec 9, 2011 Dec 17, 2011 Dec 20, 2011 Dec 27, 2011 Jan 4, 2012 Jan 10, 2012 Jan 24, 2012 Jan 26, 2012 Jan 28, 2012 Mar 9, 2012 Mar 11, 2012 Apr 25, 2012 May 5, 2012 May 18, 2012 May 19, 2012 Jun 5, 2012 Jun 7, 2012 Jul 13, 2012 Jul 19, 2012 Aug 22, 2012 Aug 28, 2012 Aug 30, 2012 Sep 9, 2012 Sep 20, 2012 Sep 21, 2012 Sep 24, 2012 Oct 1, 2012 Oct 2, 2012 Oct 4, 2012 Oct 5, 2012 Oct 16, 2012 Feb 5, 2013 Apr 11, 2013 Apr 24, 2013 May 1, 2013 May 8, 2013 May 18, 2013 May 23, 2013 Jun 2, 2013 Jun 7, 2013 Jun 13, 2013 Jul 2, 2013 Jul 3, 2013 Jul 4, 2013 Jul 20, 2013 Jul 28, 2013 Jul 30, 2013 Aug 17, 2013 Aug 25, 2013 Sep 5, 2013 Sep 10, 2013 Nov 3, 2013 May 13, 2014 May 14, 2014